ANEW MEDICAL, INC. Announces Patents Issued in Major Asian Markets for use of Genetic Therapy in the Treatment of Alzheimer’s Disease and ALS

August 8, 2024

https://www.globenewswire.com/news-release/2024/08/08/2926653/0/en/ANEW-MEDICAL-INC-Announces-Patents-Issued-in-Major-Asian-Markets-for-use-of-Genetic-Therapy-in-the-Treatment-of-Alzheimer-s-Disease-and-ALS.html

NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) — ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ:WENA) a US-based biotechnology company focused on developing cell- and gene-based treatments to affect aging and age-related diseases, announces the grant and issuance of patent number HK1259628 protecting the development of novel genetic approaches for the treatment of neurodegenerative diseases to include Alzheimer’s disease, Parkinson’s diseases and amyotrophic lateral sclerosis (“ALS”).

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.